Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years: long-term results of two phase 3 studies of secukinumab

T K Kvien; L Gossec; P Conaghan; M Østergaard; J. Cañete; C Gaillez; S Mpofu; E Davenport; S Jugl

doi:10.1080/03009742.2016.1207299

Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years: long-term results of two phase 3 studies of secukinumab

T K Kvien, L Gossec, P Conaghan, M Østergaard, J. Cañete, C Gaillez, S Mpofu, E Davenport, S Jugl

Department of Clinical Medicine

Original language	English
Article number	PP39
Journal	Scandinavian Journal of Rheumatology
Volume	45
Issue number	sup128
Number of pages	1
ISSN	0300-9742
DOIs	https://doi.org/10.1080/03009742.2016.1207299
Publication status	Published - 2016

Access to Document

10.1080/03009742.2016.1207299

Cite this

Kvien, T. K., Gossec, L., Conaghan, P., Østergaard, M., Cañete, J., Gaillez, C., Mpofu, S., Davenport, E., & Jugl, S. (2016). Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years: long-term results of two phase 3 studies of secukinumab. Scandinavian Journal of Rheumatology, 45(sup128), [PP39]. https://doi.org/10.1080/03009742.2016.1207299

Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years : long-term results of two phase 3 studies of secukinumab. / Kvien, T K; Gossec, L; Conaghan, P et al.

In: Scandinavian Journal of Rheumatology, Vol. 45, No. sup128, PP39, 2016.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Kvien, TK, Gossec, L, Conaghan, P, Østergaard, M, Cañete, J, Gaillez, C, Mpofu, S, Davenport, E & Jugl, S 2016, 'Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years: long-term results of two phase 3 studies of secukinumab', Scandinavian Journal of Rheumatology, vol. 45, no. sup128, PP39. https://doi.org/10.1080/03009742.2016.1207299

@article{2f6774a47df34082aefe6f5d0626990d,

title = "Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years: long-term results of two phase 3 studies of secukinumab",

author = "Kvien, {T K} and L Gossec and P Conaghan and M {\O}stergaard and J. Ca{\~n}ete and C Gaillez and S Mpofu and E Davenport and S Jugl",

year = "2016",

doi = "10.1080/03009742.2016.1207299",

language = "English",

volume = "45",

journal = "Scandinavian Journal of Rheumatology",

issn = "0300-9742",

publisher = "Taylor & Francis",

number = "sup128",

}

TY - ABST

T1 - Reduction in fatigue in patients with active psoriatic arthritis is sustained over 2 years

T2 - long-term results of two phase 3 studies of secukinumab

AU - Kvien, T K

AU - Gossec, L

AU - Conaghan, P

AU - Østergaard, M

AU - Cañete, J.

AU - Gaillez, C

AU - Mpofu, S

AU - Davenport, E

AU - Jugl, S

PY - 2016

Y1 - 2016

U2 - 10.1080/03009742.2016.1207299

DO - 10.1080/03009742.2016.1207299

M3 - Conference abstract in journal

SN - 0300-9742

VL - 45

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

IS - sup128

M1 - PP39

ER -